IOVA – Iovance Biotherapeutics Inc
Investors holding1
Combined shares521,546
Combined reported value$7.7M
IOVA chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Ray Dalio narrow view | 0.03 | New | 521,546 | $7.7M | Q3 2026 |
| Paul Tudor Jones | 0.00 | Closed | 0 | – | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Ray Dalio narrow view | New | 521,546 | 0.03 |
| Q3 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.01 |
| Q2 2026 | Paul Tudor Jones narrow view | Added 36.1% | 293,989 | 0.00 |
| Q1 2026 | Paul Tudor Jones narrow view | Added 20.3% | 216,004 | 0.00 |
| Q4 2025 | Paul Tudor Jones narrow view | Added 47.4% | 179,494 | 0.00 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Ray Dalio narrow view | New | 521,546 | 0.03 |
| Q2 2026 | Paul Tudor Jones narrow view | Added 36.1% | 293,989 | 0.00 |
| Q1 2026 | Paul Tudor Jones narrow view | Added 20.3% | 216,004 | 0.00 |
| Q4 2025 | Paul Tudor Jones narrow view | Added 47.4% | 179,494 | 0.00 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.01 |
History
2 peakQ3 2026: 1 tracked investors
20172026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Ray Dalio | 521.5K | – | – | – | – | – | – | – |
| Paul Tudor Jones | – | 294.0K | 216.0K | 179.5K | 121.7K | – | 122.9K | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).